LIFE-THREATENING SPONTANEOUS INTRACRANIAL BLEED IN YOUNG PATIENT WITH SEVERE FACTOR XI DEFICIENCY REQUIRING LIFELONG PROPHYLACTIC TREATMENT

被引：0
|
作者：
Mussert, C. [1 ]
Cnossen, M. [1 ]
机构：
[1] Erasmus MC Sophia Childrens Hosp, Univ Med Ctr Rotterdam, Dept Pediat Hematol & Oncol, Rotterdam, Netherlands
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ABS-02
引用
收藏
页码：52 / 52
页数：1
相关论文
共 25 条
  • [21] ARTERIAL AND VENOUS THROMBOSIS AND NORMAL RESPONSE TO STREPTOKINASE TREATMENT IN A YOUNG PATIENT WITH SEVERE HAGEMAN-FACTOR DEFICIENCY
    HELLSTERN, P
    KOHLER, M
    SCHMENGLER, K
    DOENECKE, P
    WENZEL, E
    ACTA HAEMATOLOGICA, 1983, 69 (02) : 123 - 126
  • [22] Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor
    Hayashi, T
    Tanaka, I
    Shima, M
    Yoshida, K
    Fukuda, K
    Sakurai, Y
    Matsumoto, T
    Giddings, JC
    Yoshioka, A
    HAEMOPHILIA, 2004, 10 (04) : 397 - 400
  • [23] Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?
    Carnevale-Schianca, Fabrizio
    Gallo, Susanna
    Rota-Scalabrini, Delia
    Sangiolo, Dario
    Fizzotti, Marco
    Caravelli, Daniela
    Capaldi, Antonio
    Anselmetti, Giancarlo
    Palesandro, Erica
    D'Ambrosio, Lorenzo
    Coha, Valentina
    Obert, Remo
    Aglietta, Massimo
    Grignani, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : E691 - E693
  • [24] SUCCESSFUL COMPASSIONATE USE OF RECOMBINANT ACTIVATED FACTOR-VII (NOVOSEVEN), AFTER DIFFERENT MULTIPLE CHOICES OF TREATMENT, IN A PATIENT AFFECTED BY ACQUIRED HEMOPHILIA WITH A LIFE-THREATENING RETROPERITONEAL HEMATOMA
    SCHIAVONI, M
    ETTORRE, C
    FASANO, A
    TRIGGIANI, G
    BRUCOLI, C
    CIAVARELLA, N
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1422 - 1422
  • [25] Tocilizumab as an effective treatment in cytokine release syndrome as an early peri-transplant complications in patients subjected to allogeneic stem cell transplantation-proinfammatory/autoimmune patient/donor HLA haplotype life-threatening early allogeneic HSCT complication risk factor hypothesis
    Patrycja, M-G
    Beata, P-J
    Marcin, S.
    Ksenia, K.
    Agnieszka, S-K
    Aleksander, S. B.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S318 - S319
123